Physicians' Academy for Cardiovascular Education

Cardiorenal cross-talk in diabetes: The preventive challenge in DKD for GLP-1 RA

Meeting report with video, highlights and slides of a PACE-CME symposium held during virtual ERA-EDTA 2020 on the preventive challenge in DKD for GLP-1 RA

Cardiorenal cross-talk in diabetes: The preventive challenge in DKD for GLP-1RA

EBAC-accredited E-Learning

Online-CME - This course consists of 3 parts.
This course consists of 3 parts.

In this e-learning course, participants will learn about diabetic kidney disease and how to manage patients with DKD. Member registration (free) is needed to enroll in this course.

Targeting kidney outcomes in DKD: Can GLP-1RA provide kidney protection?

10' education - July 21, 2020 - Prof. Johannes Mann, MD
Recent CVOTs with GLP-1RAs included kidney outcomes as secondary endpoint. Johannes Mann presents kidney results of these trials and raises questions from a nephrologist's perspective.

Recent CVOTs with GLP-1RAs included kidney outcomes as a secondary endpoint. Johannes Mann presents kidney results of these trials and raises questions from a nephrologist's perspective.

Diabetes and CKD: is it all about managing glucose?

10' education - July 1, 2020 - Prof. Melanie Davies, MD
Prof. Davies talks about the interrelationship between T2DM, CVD (including heart failure) and CKD and how treatment with GLP-1RAs affects these interrelated systems.

Prof. Davies talks about the interrelationship between T2DM, CVD (including heart failure) and CKD and how treatment with GLP-1RAs affects these interrelated systems.

DKD and CV risk: What is the potential of targeting GLP-1?

10' education - June 16, 2020 - Prof. Erik Stroes, MD
Patients with diabetic kidney disease (DKD) have an unmet residual CV risk. Prof. Stroes brings up some novel opportunities to treat this risk and elaborates on mechanisms of CV benefit by GLP-1RAs.

Patients with diabetic kidney disease (DKD) have an unmet residual CV risk. Prof. Stroes brings up some novel opportunities to treat this risk and elaborates on mechanisms of CV benefit by GLP-1RAs.

Slides: Targeting renal outcomes in DKD: Can GLP-1 RA provide renal protection?

Slides (presentation) - June 10, 2020 - Johannes Mann, MD – Munich, Germany - CME symposium held during ERA EDTA Virtual Congress 2020
This lecture by prof. Johannes Mann was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Diabetes and CKD: Is it all about managing glucose?

Slides (presentation) - June 10, 2020 - Melanie Davies, MD – Leicester, United Kingdom - CME symposium held during ERA EDTA Virtual Congress 2020
This lecture by prof. Melanie Davies was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: DKD & cardiovascular risk: What is the potential for targeting GLP-1?

Slides (presentation) - June 10, 2020 - Erik Stroes, MD – Amsterdam, The Netherlands - CME symposium held during ERA EDTA Virtual Congress 2020
This lecture by prof. Erik Stroes was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Cardiorenal cross-talk in diabetes: The preventive challenge in DKD for GLP-1 RA